Timo J. Oberstein

Erlangen, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Psychotherapy in inpatient psychiatry: from staffing levels to patient contact time

Psychotherapy in inpatient psychiatry: from staffing levels to patient contact time

Journal: Der Nervenarzt

Published: November 28, 2025

Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy with non-hemorrhagic imaging marker.

Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy with non-hemorrhagic imaging marker.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: October 31, 2025

Clinical Validation of Novel Immunoassays for Plasma Phosphorylated Tau 217, 212, 181, 231, and Brain-Derived Tau Across the Biochemical Spectrum of Alzheimer's Disease.

Clinical Validation of Novel Immunoassays for Plasma Phosphorylated Tau 217, 212, 181, 231, and Brain-Derived Tau Across the Biochemical Spectrum of Alzheimer's Disease.

Journal: Journal of neurochemistry

Published: July 16, 2025

Reduced serum AHR agonistic activity reflects amyloid dysregulation in AT1 subtypes of Alzheimer's disease.

Reduced serum AHR agonistic activity reflects amyloid dysregulation in AT1 subtypes of Alzheimer's disease.

Journal: Alzheimer's research & therapy

Published: June 11, 2025

Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease.

Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease.

Journal: The journal of prevention of Alzheimer's disease

Published: May 20, 2025

Comparison of ERlangen Score with pTau/Aβ1-42 Ratio for Predicting Cognitive Decline and Conversion to Alzheimer's Disease.

Comparison of ERlangen Score with pTau/Aβ1-42 Ratio for Predicting Cognitive Decline and Conversion to Alzheimer's Disease.

Journal: Brain sciences

Published: February 10, 2025

Novel, standardized sample collection from the brain-nose interface.

Novel, standardized sample collection from the brain-nose interface.

Journal: Methods (San Diego, Calif.)

Published: September 30, 2024

Reconceptualization of the Erlangen Score for the Assessment of Dementia Risk: The ERlangen Score.

Reconceptualization of the Erlangen Score for the Assessment of Dementia Risk: The ERlangen Score.

Journal: Journal of Alzheimer's disease : JAD

Published: September 24, 2023

Digit Ratio (2D:4D) Is Not Associated with Alzheimer's Disease in the Elderly.

Digit Ratio (2D:4D) Is Not Associated with Alzheimer's Disease in the Elderly.

Journal: Brain sciences

Published: July 24, 2023

PASSED: Brain atrophy in non-demented individuals in a long-term longitudinal study from two independent cohorts.

PASSED: Brain atrophy in non-demented individuals in a long-term longitudinal study from two independent cohorts.

Journal: Frontiers in aging neuroscience

Published: December 11, 2022

Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy.

Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy.

Journal: Brain communications

Published: September 27, 2022

The Cost of Early Diagnosis of Cognitive Decline in German Memory Clinics

The Cost of Early Diagnosis of Cognitive Decline in German Memory Clinics

Journal: Fortschritte der Neurologie-Psychiatrie

Published: July 20, 2022

Showing 1-12 of 35

Last Updated: 09/26/2026